ciclopirox has been researched along with Hepatitis B, Chronic in 1 studies
Hepatitis B, Chronic: INFLAMMATION of the LIVER in humans caused by HEPATITIS B VIRUS lasting six months or more. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kang, JA | 1 |
| Kim, S | 1 |
| Park, M | 1 |
| Park, HJ | 1 |
| Kim, JH | 1 |
| Park, S | 1 |
| Hwang, JR | 1 |
| Kim, YC | 1 |
| Jun Kim, Y | 1 |
| Cho, Y | 1 |
| Sun Jin, M | 1 |
| Park, SG | 1 |
1 other study available for ciclopirox and Hepatitis B, Chronic
| Article | Year |
|---|---|
Ciclopirox inhibits Hepatitis B Virus secretion by blocking capsid assembly.
Topics: Animals; Antiviral Agents; Capsid; Ciclopirox; Crystallography, X-Ray; Disease Models, Animal; Drug | 2019 |